Evaluation of the Revised Criteria for Biological and Clinical Staging of Alzheimer Disease

Copathologies play an important role in symptom severity in individuals who harbor less tau-tangle pathology than expected for their clinical impairment. These results highlight the importance of measuring non-AD biomarkers in patients with AD with worse cognitive impairment than expected based on their biological stage, which could impact the clinical diagnosis and prognosis.

Authors

Institutions

Publication Details

Journal
JAMA Neurology
Published
2025-05-19
DOI
https://doi.org/10.1001/jamaneurol.2025.1100
Citations
27
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
39.72

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of the Revised Criteria for Biological and Clinical Staging of Alzheimer Disease

Donna Masterman, Evan Fletcher, Emily A. Largent, Winnie Kwang et al.
27 citations
JAMA Neurology
Dementia and Cognitive Impairment Research
39.72
article

Evaluation of the Revised Criteria for Biological and Clinical Staging of Alzheimer Disease

Donna Masterman, Evan Fletcher, Emily A. Largent, Winnie Kwang, Clifford R. Jack, Payam Mahboubi, Magdalena Korecka, Alexander Knaack, Robert I. Reid, Juliet Fockler, Duygu Tosun, Richard J. Perrin, Jason Karlawish, Alexa Pichet Binette, Nina Silverberg, Arthur W. Toga, Sophia I. Thomopoulos, Shannon L. Risacher, Nick C. Fox, Neda Jahanshad, Karen Crawford, Lisa Thomas, Piero Parchi, Sebastian Palmqvist, Rik Ossenkoppele, Miriam T. Ashford, Erik Stomrud, Andrea Fidell, John Q. Trojanowki, Mónica Rivera Mindt, Andrew J. Saykin, Lisa L. Barnes, Erin Franklin, Elizabeth Shaffer, Marie Bernard, Pontus Tideman, Joe Strong, Cecily Jenkins, Arvin Forghanian-Arani, Michael Donohue, Tom Montine, Yuliana Cabrera, Kristin Harkins, Liana G. Apostolova, Paul S. S Aisen, Stephanie Rossi Chen, John Hsiao, Caitie Hedberg, Danielle Harvey, Charles DeCarli, Perminder Singh Sachdev, Jeremy Pizzola, Ruben Smith, Prashanthi Vemuri, Jonathan Jackson, Sheila Ogwang, Niklas Mattsson, Sarah Walter, Maria Carrillo, Diana Truran Sacrey, Joel P. Felmlee, Zoë Potter, Sandhitsu R. Das, Kaci Lacy, Magdalena Brylska, Tatiana Foroud, Mark Choe, Oskar Hansson, Taeho Jo, Matthew L. Senjem, Haley Bernhardt, Caileigh Zimmerman, Gil Dan Rabinovici, Taylor Clanton, Bret Borowski, Derek Flenniken, Zaven Kachaturian, Victor L. Villemagne, Laurel Beckett, Joshua D. Grill, Paul A. Yushkevich, Christopher G. Schwarz, Gemma Salvadó, Chengshi Jin, Olusegun Adegoke, Isabelle Glans, Colin Groot, Edward B. Lee, John C. Morris, Virginia M.‐Y. Lee, Rema Raman, Brian J. Lopresti, Kelly Nudelman, Neil Buckholtz, Nigel J. Cairns, Ian B. Malone, Danielle van Westen, Héctor Alfredo Baptista González, Eliezer Masliah, Talia M. Nir, Cat Conti, Richard Frank, Vanessa Guzmán, Kaj Blennow, Melanie J. Miller, Lindsey Hergesheimer, Rachel L. Nosheny, Sandra Talavera, Erin Drake, Robert A. Koeppe, Adrienne Kormos, Paul Thompson, Susan Landau, Peter J. Snyder, Kwangsik Nho, Zaven S. Khachaturian, Calvin Reyes, Hannah Craft, Yang Wan, Li Shen, Leslie M. Shaw, Robert C. Green, Claire M. Erickson, Stephanie Smith, Justin Robison, Naomi Saito, Michael Walter Weiner, Denise A. Reyes, Laurie Ryan, Kelley Faber, Virginia Boatwright, Joseph Di Benedetto, Hannatu Amaza, Omobolanle Ayo, Trinity Weisensel, John Moore-Weiss, Leonard Matoush, Shaniya Parkins, Matt Glittenberg, Kaori Kubo Germano, William Z. Potter, William Jagust, Carole Ho, Shorena Janelidze, Adam Diaz, Scott Neu, Susan Molchan, Fabiola Magana, Leon J. Thal, Ronald Petersen, Rima Kaddurah-Daouk, Michael Rafii, Isabella Hoang, Adeyinka Ajayi, Mai Seng Thao, Henrik Zetterberg, Jennifer Salazar, Lisa Taylor‐Reinwald, Chad Ward, Jeff Gunter, Caitlin Webb, Kedir Adem Hussen, Kejal Kantarci, Gustavo Jiménez
article en
27 citations

Abstract

Copathologies play an important role in symptom severity in individuals who harbor less tau-tangle pathology than expected for their clinical impairment. These results highlight the importance of measuring non-AD biomarkers in patients with AD with worse cognitive impairment than expected based on their biological stage, which could impact the clinical diagnosis and prognosis.

JAMA NeurologyVol. 82(7)
University of Science and Technology of China (CN), Lund University (SE), Sahlgrenska University Hospital (SE), Sorbonne Université (FR), Alzheimer’s Disease Neuroimaging Initiative (US), Pitié-Salpêtrière Hospital (FR), Istituto delle Scienze Neurologiche di Bologna (IT), UK Dementia Research Institute (GB), Institut Universitaire de Gériatrie de Montréal (CA), Skåne University Hospital (SE), Institut du Cerveau (FR), University College London (GB), Université de Montréal (CA), Vrije Universiteit Amsterdam (NL), University of Gothenburg (SE), University of Bologna (IT)
Alzheimer's Association, University of Wisconsin-Madison, GHR Foundation, Lunds Universitet, Knut och Alice Wallenbergs Stiftelse, Vetenskapsrådet, Sahlgrenska Universitetssjukhuset, Göteborgs Universitet, Università di Bologna, University of Science and Technology of China, Skånes universitetssjukhus, UK Dementia Research Institute, Sorbonne Université, School of Medicine and Public Health, University of Wisconsin-Madison, Sahlgrenska Akademin, School of Life Sciences and Biotechnology Division of Life Sciences, Korea University
Openalex Percentile: Top 0%
Dementia and Cognitive Impairment Research
39.72
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.